Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kimbrell, 2001, The evolution and genetics of innate immunity, Nat. Rev. Genet., 2, 256, 10.1038/35066006
Buchmann, 2014, Evolution of Innate Immunity: Clues from Invertebrates via Fish to Mammals, Front. Immunol., 5, 459, 10.3389/fimmu.2014.00459
Kumar, 2014, Innate lymphoid cells: new paradigm in immunology of inflammation, Immunol. Lett., 157, 23, 10.1016/j.imlet.2013.11.003
Kumar, 2010, Neutrophils: Cinderella of innate immune system, Int. Immunopharmacol., 10, 1325, 10.1016/j.intimp.2010.08.012
Silva, 2010, When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system, J. Leukoc. Biol., 87, 93, 10.1189/jlb.0809549
Galli, 2011, Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils, Nat. Immunol., 12, 1035, 10.1038/ni.2109
Kolaczkowska, 2013, Neutrophil recruitment and function in health and inflammation, Nat. Rev. Immunol., 13, 159, 10.1038/nri3399
de Oliveira, 2016, Neutrophil migration in infection and wound repair: going forward in reverse, Nat. Rev. Immunol., 16, 378, 10.1038/nri.2016.49
Kumar, 2017, Role of MAIT cells in the immunopathogenesis of inflammatory diseases: New players in old game, Int. Rev. Immunol., 1, 10.1080/08830185.2017.1290936
Morgan, 2015, Complement, a target for therapy in inflammatory and degenerative diseases, Nat. Rev. Drug Discov., 14, 857, 10.1038/nrd4657
Pasupuleti, 2012, Antimicrobial peptides: key components of the innate immune system, Crit. Rev. Biotechnol., 32, 143, 10.3109/07388551.2011.594423
Wiesner, 2010, Antimicrobial peptides: the ancient arm of the human immune system, Virulence, 1, 440, 10.4161/viru.1.5.12983
Diamond, 2009, The Roles of Antimicrobial Peptides in Innate Host Defense, Curr. Pharm. Des., 15, 2377, 10.2174/138161209788682325
Radek, 2007, Antimicrobial peptides: natural effectors of the innate immune system, Semin. Immunopathol., 29, 27, 10.1007/s00281-007-0064-5
Wagner, 2010, Therapeutic potential of complement modulation, Nat. Rev. Drug Discov., 9, 43, 10.1038/nrd3011
Dunkelberger, 2009, Complement and its role in innate and adaptive immune responses, Cell Res., 20, 34, 10.1038/cr.2009.139
Kumar, 2008, Innate immunity in sepsis pathogenesis and its modulation: new immunomodulatory targets revealed, J. Chemother., 20, 672, 10.1179/joc.2008.20.6.672
Areschoug, 2008, Pattern recognition receptors and their role in innate immunity: focus on microbial protein ligands, Contrib. Microbiol., 15, 45, 10.1159/000135685
Kumagai, 2010, Identification and functions of pattern-recognition receptors, J. Allergy Clin. Immunol., 125, 985, 10.1016/j.jaci.2010.01.058
Takeuchi, 2010, Pattern recognition receptors and inflammation, Cell, 140, 805, 10.1016/j.cell.2010.01.022
Azumi, 2003, Genomic analysis of immunity in a Urochordate and the emergence of the vertebrate immune system: "waiting for Godot", Immunogenetics, 55, 570, 10.1007/s00251-003-0606-5
Tenor, 2008, A conserved Toll-like receptor is required for Caenorhabditis elegans innate immunity, EMBO Rep., 9, 103, 10.1038/sj.embor.7401104
Irazoqui, 2010, Evolution of host innate defence: insights from C. elegans and primitive invertebrates, Nat. Rev. Immunol., 10, 47, 10.1038/nri2689
Brandt, 2015, Toll-like Receptor Signaling Promotes Development and Function of Sensory Neurons Required for a C. elegans Pathogen-Avoidance Behavior, Curr. Biol., 25, 2228, 10.1016/j.cub.2015.07.037
Hashimoto, 1988, The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein, Cell, 52, 269, 10.1016/0092-8674(88)90516-8
Medzhitov, 1997, A human homologue of the Drosophila Toll protein signals activation of adaptive immunity, Nature, 388, 394, 10.1038/41131
Vaure, 2014, A comparative review of toll-like receptor 4 expression and functionality in different animal species, Front. Immunol., 5, 316, 10.3389/fimmu.2014.00316
Leulier, 2008, Toll-like receptors—taking an evolutionary approach, Nat. Rev. Genet., 9, 165, 10.1038/nrg2303
Roach, 2005, The evolution of vertebrate Toll-like receptors, Proc. Natl. Acad. Sci. U. S. A., 102, 9577, 10.1073/pnas.0502272102
Rast, 2006, Genomic insights into the immune system of the sea urchin, Science, 314, 952, 10.1126/science.1134301
Kawai, 2007, Antiviral signaling through pattern recognition receptors, J. Biochem., 141, 137, 10.1093/jb/mvm032
Coban, 2007, Pathological role of Toll-like receptor signaling in cerebral malaria, Int. Immunol., 19, 67, 10.1093/intimm/dxl123
Akira, 2006, TLR signaling, Curr. Top. Microbiol. Immunol., 311, 1
Uematsu, 2006, Toll-like receptors and innate immunity, J. Mol. Med., 84, 712, 10.1007/s00109-006-0084-y
Liu, 2007, Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4(+) CD25(+) T cells, Immunology, 122, 149, 10.1111/j.1365-2567.2007.02651.x
Manicassamy, 2009, Modulation of adaptive immunity with Toll-like receptors, Semin. Immunol., 21, 185, 10.1016/j.smim.2009.05.005
Majewska, 2006, The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation, Postepy Hig. Med. Dosw., 60, 52
Gerttula, 1988, Zygotic expression and activity of the Drosophila Toll gene, a gene required maternally for embryonic dorsal-ventral pattern formation, Genetics, 119, 123, 10.1093/genetics/119.1.123
Lemaitre, 1996, The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults, Cell, 86, 973, 10.1016/S0092-8674(00)80172-5
Medzhitov, 1997, Innate immunity: the virtues of a nonclonal system of recognition, Cell, 91, 295, 10.1016/S0092-8674(00)80412-2
Rock, 1998, A family of human receptors structurally related to Drosophila Toll, Proc. Natl. Acad. Sci. U. S. A., 95, 588, 10.1073/pnas.95.2.588
Poltorak, 1998, Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region, Blood Cells Mol. Dis., 24, 340, 10.1006/bcmd.1998.0201
Poltorak, 1998, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene, Science (New York, N.Y.), 282, 2085, 10.1126/science.282.5396.2085
Beutler, 2000, The search for Lps: 1993–1998, J. Endotoxin Res., 6, 269, 10.1177/09680519000060040401
Beutler, 2000, Tlr4: central component of the sole mammalian LPS sensor, Curr. Opin. Immunol., 12, 20, 10.1016/S0952-7915(99)00046-1
Janeway, 1992, The immune system evolved to discriminate infectious nonself from noninfectious self, Immunol. Today, 13, 11, 10.1016/0167-5699(92)90198-G
Medzhitov, 1997, Innate immunity: impact on the adaptive immune response, Curr. Opin. Immunol., 9, 4, 10.1016/S0952-7915(97)80152-5
Fallon, 2001, Primitive Toll signalling: bugs, flies, worms and man, Trends Immunol., 22, 63, 10.1016/S1471-4906(00)01800-7
Wasserman, 2000, Toll signaling: the enigma variations, Curr. Opin. Genet. Dev., 10, 497, 10.1016/S0959-437X(00)00118-0
Kawai, 2011, Toll-like receptors and their crosstalk with other innate receptors in infection and immunity, Immunity, 34, 637, 10.1016/j.immuni.2011.05.006
Imler, 2001, Toll receptors in innate immunity, Trends Cell Biol., 11, 304, 10.1016/S0962-8924(01)02004-9
Du, 2000, Three novel mammalian toll-like receptors: gene structure, expression, and evolution, Eur. Cytokine Netw., 11, 362
Kawasaki, 2014, Toll-like receptor signaling pathways, Front. Immunol., 5, 461, 10.3389/fimmu.2014.00461
Fukui, 2009, Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing, J. Exp. Med., 206, 1339, 10.1084/jem.20082316
Takahashi, 2007, A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses, J. Exp. Med., 204, 2963, 10.1084/jem.20071132
Yang, 2007, Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages, Immunity, 26, 215, 10.1016/j.immuni.2006.12.005
Park, 2008, Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9, Nat. Immunol., 9, 1407, 10.1038/ni.1669
Ewald, 2011, Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase, J. Exp. Med., 208, 643, 10.1084/jem.20100682
Garcia-Cattaneo, 2012, Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling, Proc. Natl. Acad. Sci. U. S. A., 109, 9053, 10.1073/pnas.1115091109
Kawai, 2009, The roles of TLRs, RLRs and NLRs in pathogen recognitionInt Immunol. 21:313, Int. Immunol., 21, 317, 10.1093/intimm/dxp017
Kumar, 2009, Toll-like receptors and innate immunity, Biochem. Biophys. Res. Commun., 388, 621, 10.1016/j.bbrc.2009.08.062
McClure, 2014, TLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial Pathogens, Front. Immunol., 5, 386, 10.3389/fimmu.2014.00386
Fitzner, 2008, Human Skin Endothelial Cells Can Express All 10 TLR Genes and Respond to Respective Ligands, Clin. Vaccine Immunol., 15, 138, 10.1128/CVI.00257-07
Hemmi, 2005, TLR signalling and the function of dendritic cells, Chem. Immunol. Allergy, 86, 120, 10.1159/000086657
Khakpour, 2015, Vascular endothelial cell Toll-like receptor pathways in sepsis, Innate Immun., 21, 827, 10.1177/1753425915606525
Nagyoszi, 2010, Expression and regulation of toll-like receptors in cerebral endothelial cells, Neurochem. Int., 57, 556, 10.1016/j.neuint.2010.07.002
Sandig, 2012, TLR signaling in mast cells: common and unique features, Front. Immunol., 3, 185, 10.3389/fimmu.2012.00185
Young, 2004, Expression of Toll-like Receptors in Human Endometrial Epithelial Cells and Cell Lines, Am. J. Reprod. Immunol., 52, 67, 10.1111/j.1600-0897.2004.00189.x
Trudler, 2010, Toll-Like Receptors Expression and Signaling in Glia Cells in Neuro-Amyloidogenic Diseases: Towards Future Therapeutic Application, Mediat. Inflamm., 2010, 12, 10.1155/2010/497987
Jack, 2005, TLR signaling tailors innate immune responses in human microglia and astrocytes, J. Immunol., 175, 4320, 10.4049/jimmunol.175.7.4320
Hornef, 2003, Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells, J. Exp. Med., 198, 1225, 10.1084/jem.20022194
Shuang, 2007, Differential expression of Toll-like receptor 2 (TLR2) and responses to TLR2 ligands between human and murine vascular endothelial cells, J. Endotoxin Res., 13, 281, 10.1177/0968051907085096
Kono, 2009, Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus, Proc. Natl. Acad. Sci. U. S. A., 106, 12061, 10.1073/pnas.0905441106
Pandey, 2014, Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors, Cold Spring Harb. Perspect. Biol., 7, a016246, 10.1101/cshperspect.a016246
Tartey, 2017, Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells, Int. Rev. Immunol., 36, 57, 10.1080/08830185.2016.1261318
Vidya, 2017, Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals, Int. Rev. Immunol., 1
Goulopoulou, 2016, Toll-like Receptors in the Vascular System: Sensing the Dangers Within, Pharmacol. Rev., 68, 142, 10.1124/pr.114.010090
Kawai, 2010, The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors, Nat. Immunol., 11, 373, 10.1038/ni.1863
O'Connor, 2006, Putting the natural killer cell in its place, Immunology, 117, 1, 10.1111/j.1365-2567.2005.02256.x
Sivori, 2014, TLR/NCR/KIR: Which One to Use and When?, Front. Immunol., 5
Szajnik, 2009, TLR4 signaling induced by lipopolysacharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer, Oncogene, 28, 4353, 10.1038/onc.2009.289
Pisetsky, 2008, High-mobility group box protein 1 (HMGB1): an alarm in mediating the pathogenesis of rheumatic disease, Arthritis Res. Ther., 10, 209, 10.1186/ar2440
Wang, 2014, Targeting HMGB1 in the treatment of sepsis, Expert Opin. Ther. Targets, 18, 257, 10.1517/14728222.2014.863876
Huang, 2010, HMGB1, a potent proinflammatory cytokine in sepsis, Cytokine, 51, 119, 10.1016/j.cyto.2010.02.021
Rittirsch, 2008, Harmful molecular mechanisms in sepsis, Nat. Rev. Immunol., 8, 776, 10.1038/nri2402
Dumitriu, 2005, HMGB1: guiding immunity from within, Trends Immunol., 26, 381, 10.1016/j.it.2005.04.009
Wilhelmsen, 2012, Activation of endothelial TLR2 by bacterial lipoprotein upregulates proteins specific for the neutrophil response, Innate Immun., 18, 602, 10.1177/1753425911429336
Imaizumi, 2000, Expression of tumor necrosis factor-alpha in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1alpha, Arterioscler. Thromb. Vasc. Biol., 20, 410, 10.1161/01.ATV.20.2.410
Ranta, 1999, Human vascular endothelial cells produce tumor necrosis factor-alpha in response to proinflammatory cytokine stimulation, Crit. Care Med., 27, 2184, 10.1097/00003246-199910000-00019
Ojeda, 2005, Dialyzable leukocyte extract differentially regulates the production of TNFalpha, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells, Inflamm. Res., 54, 74, 10.1007/s00011-004-1326-5
Wilhelmsen, 2012, ERK5 protein promotes, whereas MEK1 protein differentially regulates, the Toll-like receptor 2 protein-dependent activation of human endothelial cells and monocytes, J. Biol. Chem., 287, 26478, 10.1074/jbc.M112.359489
Pegu, 2008, Human lymphatic endothelial cells express multiple functional TLRs, J. Immunol., 180, 3399, 10.4049/jimmunol.180.5.3399
Talreja, 2004, Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components, Immunology, 113, 224, 10.1111/j.1365-2567.2004.01946.x
Garrafa, 2011, Heterogeneous expression of toll-like receptors in lymphatic endothelial cells derived from different tissues, Immunol. Cell Biol., 89, 475, 10.1038/icb.2010.111
Shin, 2011, Bacterial lipoprotein TLR2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo, J. Immunol., 186, 1119, 10.4049/jimmunol.1001647
Zeuke, 2002, TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS, Cardiovasc. Res., 56, 126, 10.1016/S0008-6363(02)00512-6
Verma, 2006, Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide, Brain Behav. Immun., 20, 449, 10.1016/j.bbi.2005.10.005
Lundberg, 2007, Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems, Blood, 110, 3245, 10.1182/blood-2007-02-072934
Huang, 2009, Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists, Infect. Immun., 77, 1774, 10.1128/IAI.00086-09
Long, 2009, Lipoteichoic acid induces unique inflammatory responses when compared to other toll-like receptor 2 ligands, PLoS One, 4, 10.1371/journal.pone.0005601
Hartmann, 1999, CpG DNA and LPS induce distinct patterns of activation in human monocytes, Gene Ther., 6, 893, 10.1038/sj.gt.3300880
Boonstra, 2006, Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals, J. Immunol., 177, 7551, 10.4049/jimmunol.177.11.7551
Guiducci, 2006, Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation, J. Exp. Med., 203, 1999, 10.1084/jem.20060401
Dunzendorfer, 2004, Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses, FASEB J., 18, 1117, 10.1096/fj.03-1263fje
Baumann, 2010, CD14 is a coreceptor of Toll-like receptors 7 and 9, J. Exp. Med., 207, 2689, 10.1084/jem.20101111
Sutton, 2014, Endothelial Cells and Inflammation, 367
Pober, 2007, 7, 803
Castellon, 2016, Chronic Inflammatory Diseases and Endothelial Dysfunction, Aging Dis., 7, 81, 10.14336/AD.2015.0803
Guillerey, 2016, Targeting natural killer cells in cancer immunotherapy, Nat. Immunol., 17, 1025, 10.1038/ni.3518
Waggoner, 2016, Roles of natural killer cells in antiviral immunity, Curr. Opin. Virol., 16, 15, 10.1016/j.coviro.2015.10.008
Kumar, 2008, Emerging role of uterine natural killer cells in establishing pregnancy, Iran. J. Immunol., 5, 71
Gaynor, 2017, Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice, Front. Immunol., 8, 467, 10.3389/fimmu.2017.00467
Vacca, 2013, Natural killer cells in human pregnancy, J. Reprod. Immunol., 97, 14, 10.1016/j.jri.2012.10.008
Lee, 2013, Neonatal Natural Killer Cell Function: Relevance to Antiviral Immune Defense, Clin. Dev. Immunol., 2013, 6, 10.1155/2013/427696
Boyton, 2007, Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease, Clin. Exp. Immunol., 149, 1, 10.1111/j.1365-2249.2007.03424.x
Boudreau, 2018, Natural killer cell education in human health and disease, Curr. Opin. Immunol., 50, 102, 10.1016/j.coi.2017.11.003
Jamieson, 2002, The role of the NKG2D immunoreceptor in immune cell activation and natural killing, Immunity, 17, 19, 10.1016/S1074-7613(02)00333-3
Spear, 2013, NKG2D ligands as therapeutic targets, Cancer Immun., 13, 8
Berry, 2014, The Ly49 natural killer cell receptors: a versatile tool for viral self-discrimination, Immunol. Cell Biol., 92, 214, 10.1038/icb.2013.100
Rahim, 2014, Ly49 Receptors: Innate and Adaptive Immune Paradigms, Front. Immunol., 5, 145, 10.3389/fimmu.2014.00145
Mager, 2001, Evolution of natural killer cell receptors: coexistence of functional Ly49 and KIR genes in baboons, Curr. Biol., 11, 626, 10.1016/S0960-9822(01)00148-8
Thielens, 2012, NK cell MHC class I specific receptors (KIR): from biology to clinical intervention, Curr. Opin. Immunol., 24, 239, 10.1016/j.coi.2012.01.001
Boudreau, 2018, Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned, Trends Immunol., 39, 222, 10.1016/j.it.2017.12.001
Ashouri, 2014, Presence of more activating KIR genes is associated with Hashimoto's thyroiditis, Endocrine, 46, 519, 10.1007/s12020-013-0080-2
Li, 2016, Killer cell immunoglobulin-like receptor genes and their hla-c ligands in hashimoto thyroiditis in a chinese population, Endocr. Pract., 22, 935, 10.4158/EP151175.OR
Vilches, 2002, KIR: diverse, rapidly evolving receptors of innate and adaptive immunity, Annu. Rev. Immunol., 20, 217, 10.1146/annurev.immunol.20.092501.134942
Adib-Conquy, 2013, TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals, Immunol. Cell Biol., 92, 256, 10.1038/icb.2013.99
Sivori, 2010, A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2, Blood, 116, 1637, 10.1182/blood-2009-12-256586
Lodoen, 2006, Natural killer cells as an initial defense against pathogens, Curr. Opin. Immunol., 18, 391, 10.1016/j.coi.2006.05.002
Sivori, 2010, Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products, Trends Immunol., 31, 289, 10.1016/j.it.2010.05.007
Guo, 2012, Critical role of Toll-like receptor signaling in NK cell activation, Chin. Sci. Bull., 57, 3192, 10.1007/s11434-012-5257-1
Vankayalapati, 2005, Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium, J. Immunol., 175, 4611, 10.4049/jimmunol.175.7.4611
Guerra, 2012, Control of Mycobacterium tuberculosis growth by activated natural killer cells, Clin. Exp. Immunol., 168, 142, 10.1111/j.1365-2249.2011.04552.x
Lauzon, 2006, The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity, Cell. Immunol., 241, 102, 10.1016/j.cellimm.2006.08.004
Chalifour, 2004, Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production, Blood, 104, 1778, 10.1182/blood-2003-08-2820
Popko, 2015, The role of natural killer cells in pathogenesis of autoimmune diseases, Cent. Eur. J. Immunol., 40, 470, 10.5114/ceji.2015.56971
Huang, 2009, Role of toll like receptors in rheumatoid arthritis, Curr. Rheumatol. Rep., 11, 357, 10.1007/s11926-009-0051-z
Tadema, 2011, Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis, PLoS One, 6, 10.1371/journal.pone.0024315
Adib-Conquy, 2014, TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals, Immunol. Cell Biol., 92, 256, 10.1038/icb.2013.99
Saikh, 2003, Toll-like receptor and cytokine expression patterns of CD56+ T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons, J. Infect. Dis., 188, 1562, 10.1086/379196
Eriksson, 2006, TLRs mediate IFN-gamma production by human uterine NK cells in endometrium, J. Immunol., 176, 6219, 10.4049/jimmunol.176.10.6219
Comin, 2007, Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis, Clin. Exp. Immunol., 149, 274, 10.1111/j.1365-2249.2007.03403.x
Souza-Fonseca-Guimaraes, 2012, NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis, J. Immunol., 188, 5850, 10.4049/jimmunol.1103616
Souza-Fonseca-Guimaraes, 2012, Toll-like receptors expression and interferon-gamma production by NK cells in human sepsis, Crit. Care, 16, R206, 10.1186/cc11838
Zipris, 2010, Toll-Like Receptors and Type 1 Diabetes, 585
Zipris, 2007, TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat, J. Immunol., 178, 693, 10.4049/jimmunol.178.2.693
Flodstrom, 2002, Target cell defense prevents the development of diabetes after viral infection, Nat. Immunol., 3, 373, 10.1038/ni771
Souza-Fonseca-Guimaraes, 2012, Natural killer (NK) cells in antibacterial innate immunity: angels or devils?, Mol. Med., 18, 270, 10.2119/molmed.2011.00201
Ebihara, 2010, Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation, J. Exp. Med., 207, 2675, 10.1084/jem.20091573
Millard, 2010, Inhibition of direct and indirect TLR-mediated activation of human NK cells by low molecular weight dextran sulfate, Mol. Immunol., 47, 2349, 10.1016/j.molimm.2010.05.284
Newman, 2007, Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens, Nat. Rev. Immunol., 7, 279, 10.1038/nri2057
Etogo, 2008, NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis, J. Immunol., 180, 6334, 10.4049/jimmunol.180.9.6334
Badgwell, 2002, Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection, Surgery, 132, 205, 10.1067/msy.2002.125311
Andaluz-Ojeda, 2011, Early natural killer cell counts in blood predict mortality in severe sepsis, Crit. Care, 15, R243, 10.1186/cc10501
Sivori, 2004, CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells, Proc. Natl. Acad. Sci. U. S. A., 101, 10116, 10.1073/pnas.0403744101
Schreibelt, 2010, Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy, Cancer Immunol. Immunother., 59, 1573, 10.1007/s00262-010-0833-1
Hochrein, 2002, Human and mouse plasmacytoid dendritic cells, Hum. Immunol., 63, 1103, 10.1016/S0198-8859(02)00748-6
Rothenfusser, 2001, Distinct CpG oligonucleotide sequences activate human gamma delta T cells via interferon-alpha/-beta, Eur. J. Immunol., 31, 3525, 10.1002/1521-4141(200112)31:12<3525::AID-IMMU3525>3.0.CO;2-5
Proietto, 2004, Differential production of inflammatory chemokines by murine dendritic cell subsets, Immunobiology, 209, 163, 10.1016/j.imbio.2004.03.002
Kawai, 2004, Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6, Nat. Immunol., 5, 1061, 10.1038/ni1118
Honda, 2004, Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling, Proc. Natl. Acad. Sci. U. S. A., 101, 15416, 10.1073/pnas.0406933101
Fuchsberger, 2005, Activation of plasmacytoid dendritic cells, Immunol. Cell Biol., 83, 571, 10.1111/j.1440-1711.2005.01392.x
Uematsu, 2005, Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction, J. Exp. Med., 201, 915, 10.1084/jem.20042372
MacDonald, 2002, Characterization of human blood dendritic cell subsets, Blood, 100, 4512, 10.1182/blood-2001-11-0097
Piccioli, 2007, Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets, Blood, 109, 5371, 10.1182/blood-2006-08-038422
Ito, 2002, Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets, J. Exp. Med., 195, 1507, 10.1084/jem.20020207
Means, 2003, The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells, J. Immunol., 170, 5165, 10.4049/jimmunol.170.10.5165
Perera, 2001, CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression, J. Immunol., 166, 574, 10.4049/jimmunol.166.1.574
Ling, 2014, Integrin CD11b positively regulates TLR4-induced signalling pathways in dendritic cells but not in macrophages, Nat. Commun., 5, 3039, 10.1038/ncomms4039
Matsuzawa, 2005, ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity, Nat. Immunol., 6, 587, 10.1038/ni1200
Mnich, 2010, Critical role for apoptosis signal-regulating kinase 1 in the development of inflammatory K/BxN serum-induced arthritis, Int. Immunopharmacol., 10, 1170, 10.1016/j.intimp.2010.06.023
Fujino, 2007, Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1, Mol. Cell. Biol., 27, 8152, 10.1128/MCB.00227-07
Noguchi, 2005, Recruitment of tumor necrosis factor receptor-associated factor family proteins to apoptosis signal-regulating kinase 1 signalosome is essential for oxidative stress-induced cell death, J. Biol. Chem., 280, 37033, 10.1074/jbc.M506771200
Fan, 2015, Alterations of dendritic cells in sepsis: featured role in immunoparalysis, Biomed. Res. Int., 2015, 903720, 10.1155/2015/903720
Hotchkiss, 2002, Depletion of dendritic cells, but not macrophages, in patients with sepsis, J. Immunol., 168, 2493, 10.4049/jimmunol.168.5.2493
Toliver-Kinsky, 2003, Stimulation of hematopoiesis by the Fms-like tyrosine kinase 3 ligand restores bacterial induction of Th1 cytokines in thermally injured mice, Infect. Immun., 71, 3058, 10.1128/IAI.71.6.3058-3067.2003
Toliver-Kinsky, 2005, Enhancement of dendritic cell production by fms-like tyrosine kinase-3 ligand increases the resistance of mice to a burn wound infection, J. Immunol., 174, 404, 10.4049/jimmunol.174.1.404
Bohannon, 2010, Dendritic cell modification of neutrophil responses to infection after burn injury, J. Immunol., 185, 2847, 10.4049/jimmunol.0903619
Hotchkiss, 2013, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy, Nat. Rev. Immunol., 13, 862, 10.1038/nri3552
Benjamim, 2003, Septic mice are susceptible to pulmonary aspergillosis, Am. J. Pathol., 163, 2605, 10.1016/S0002-9440(10)63615-2
Roquilly, 2017, Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections, Immunity, 47, 135-147.e5, 10.1016/j.immuni.2017.06.021
Benjamim, 2005, Reversal of long-term sepsis-induced immunosuppression by dendritic cells, Blood, 105, 3588, 10.1182/blood-2004-08-3251
Roquilly, 2013, Toll-like receptor-4 agonist in post-haemorrhage pneumonia: role of dendritic and natural killer cells, Eur. Respir. J., 42, 1365, 10.1183/09031936.00152612
Dar, 2014, Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses, Front. Immunol., 5, 366, 10.3389/fimmu.2014.00366
Catalan-Serra, 2017, Gammadelta T Cells in Crohn's Disease: A New Player in the Disease Pathogenesis?, J. Crohns Colitis, 11, 1135, 10.1093/ecco-jcc/jjx039
Papotto, 2018, Innately versatile: γδ17 T cells in inflammatory and autoimmune diseases, J. Autoimmun., 87, 26, 10.1016/j.jaut.2017.11.006
Gelderblom, 2014, γδ T cells as early sensors of tissue damage and mediators of secondary neurodegeneration, Front. Cell. Neurosci., 8, 368, 10.3389/fncel.2014.00368
Nielsen, 2017, γδ T cells in homeostasis and host defence of epithelial barrier tissues, Nat. Rev. Immunol., 17, 733, 10.1038/nri.2017.101
Jin, 2010, Cutting edge: Intrinsic programming of thymic gammadeltaT cells for specific peripheral tissue localization, J. Immunol., 185, 7156, 10.4049/jimmunol.1002781
Born, 2006, The function of gammadelta T cells in innate immunity, Curr. Opin. Immunol., 18, 31, 10.1016/j.coi.2005.11.007
Hayday, 2000, gammadelta cells and the regulation of mucosal immune responses, Am. J. Respir. Crit. Care Med., 162, S161, 10.1164/ajrccm.162.supplement_3.15tac4
Hayday, 2000, [gamma][delta] cells: a right time and a right place for a conserved third way of protection, Annu. Rev. Immunol., 18, 975, 10.1146/annurev.immunol.18.1.975
Alcaide, 2016, Bacterial Vaginosis Is Associated with Loss of Gamma Delta T Cells in the Female Reproductive Tract in Women in the Miami Women Interagency HIV Study (WIHS): A Cross Sectional Study, PLoS ONE, 11, 10.1371/journal.pone.0153045
Vroom, 1991, Tissue distribution of human gamma delta T cells: no evidence for general epithelial tropism, J. Clin. Pathol., 44, 1012, 10.1136/jcp.44.12.1012
Sheridan, 2013, γδ T Cells Exhibit Multifunctional and Protective Memory in Intestinal Tissues, Immunity, 39, 184, 10.1016/j.immuni.2013.06.015
Chennupati, 2010, Intra- and intercompartmental movement of gammadelta T cells: intestinal intraepithelial and peripheral gammadelta T cells represent exclusive nonoverlapping populations with distinct migration characteristics, J. Immunol., 185, 5160, 10.4049/jimmunol.1001652
Vantourout, 2013, Six-of-the-best: unique contributions of γδ T cells to immunology, Nat. Rev. Immunol., 13, 88, 10.1038/nri3384
Cho, 2010, IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice, J. Clin. Invest., 120, 1762, 10.1172/JCI40891
Molne, 2003, Role of gamma/delta T cell receptor-expressing lymphocytes in cutaneous infection caused by Staphylococcus aureus, Clin. Exp. Immunol., 132, 209, 10.1046/j.1365-2249.2003.02151.x
Asarnow, 1988, Limited diversity of gamma delta antigen receptor genes of Thy-1+ dendritic epidermal cells, Cell, 55, 837, 10.1016/0092-8674(88)90139-0
Andreu-Ballester, 2013, Association of gammadelta T cells with disease severity and mortality in septic patients, Clin. Vaccine Immunol., 20, 738, 10.1128/CVI.00752-12
Galley, 2015, Characterisation of gamma delta (gammadelta) T cell populations in patients with sepsis, Cell Biol. Int., 39, 210, 10.1002/cbin.10361
Tschop, 2008, Gammadelta T cells mitigate the organ injury and mortality of sepsis, J. Leukoc. Biol., 83, 581, 10.1189/jlb.0707507
Kim, 2017, The Role of Th-17 Cells and gammadelta T-Cells in Modulating the Systemic Inflammatory Response to Severe Burn Injury, Int. J. Mol. Sci., 18, 10.3390/ijms18040758
Zheng, 2013, gammadelta-T cells: an unpolished sword in human anti-infection immunity, Cell. Mol. Immunol., 10, 50, 10.1038/cmi.2012.43
Schwacha, 2014, Mitochondrial damage-associated molecular patterns activate gammadelta T-cells, Innate Immun., 20, 261, 10.1177/1753425913488969
Schwacha, 2016, Dermal gammadelta T-Cells Can Be Activated by Mitochondrial Damage-Associated Molecular Patterns, PLoS One, 11, 10.1371/journal.pone.0158993
Devilder, 2009, Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells, J. Immunol., 183, 3625, 10.4049/jimmunol.0901571
Pietschmann, 2009, Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes, Scand. J. Immunol., 70, 245, 10.1111/j.1365-3083.2009.02290.x
Wesch, 2011, Modulation of gammadelta T cell responses by TLR ligands, Cell. Mol. Life Sci., 68, 2357, 10.1007/s00018-011-0699-1
Wesch, 2006, Direct costimulatory effect of TLR3 ligand poly(I:C) on human gamma delta T lymphocytes, J. Immunol., 176, 1348, 10.4049/jimmunol.176.3.1348
Beetz, 2008, Innate immune functions of human gammadelta T cells, Immunobiology, 213, 173, 10.1016/j.imbio.2007.10.006
Deetz, 2006, Gamma interferon secretion by human Vgamma2Vdelta2 T cells after stimulation with antibody against the T-cell receptor plus the Toll-Like receptor 2 agonist Pam3Cys, Infect. Immun., 74, 4505, 10.1128/IAI.00088-06
Hedges, 2005, Gamma delta T cells respond directly to pathogen-associated molecular patterns, J. Immunol., 174, 6045, 10.4049/jimmunol.174.10.6045
Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat. Rev. Immunol., 9, 162, 10.1038/nri2506
Condamine, 2011, Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function, Trends Immunol., 32, 19, 10.1016/j.it.2010.10.002
Almand, 2001, Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer, J. Immunol., 166, 678, 10.4049/jimmunol.166.1.678
Peranzoni, 2010, Myeloid-derived suppressor cell heterogeneity and subset definition, Curr. Opin. Immunol., 22, 238, 10.1016/j.coi.2010.01.021
Nagaraj, 2010, Myeloid-derived suppressor cells in human cancer, Cancer J., 16, 348, 10.1097/PPO.0b013e3181eb3358
Ribechini, 2010, Subsets, expansion and activation of myeloid-derived suppressor cells, Med. Microbiol. Immunol., 199, 273, 10.1007/s00430-010-0151-4
Veglia, 2018, Myeloid-derived suppressor cells coming of age, Nat. Immunol., 19, 108, 10.1038/s41590-017-0022-x
Maruyama, 2015, Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling, Biochem. Biophys. Res. Commun., 457, 445, 10.1016/j.bbrc.2015.01.011
Bunt, 2009, Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4, J. Leukoc. Biol., 85, 996, 10.1189/jlb.0708446
Delano, 2007, MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis, J. Exp. Med., 204, 1463, 10.1084/jem.20062602
Zoglmeier, 2011, CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice, Clin. Cancer Res., 17, 1765, 10.1158/1078-0432.CCR-10-2672
Shirota, 2012, Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells, J. Immunol., 188, 1592, 10.4049/jimmunol.1101304
Ost, 2016, Myeloid-Derived Suppressor Cells in Bacterial Infections, Front. Cell. Infect. Microbiol., 6, 37, 10.3389/fcimb.2016.00037
Brudecki, 2012, Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response, Infect. Immun., 80, 2026, 10.1128/IAI.00239-12
Cuenca, 2011, A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma, Mol. Med., 17, 281, 10.2119/molmed.2010.00178
Derive, 2012, Myeloid-derived suppressor cells control microbial sepsis, Intensive Care Med., 38, 1040, 10.1007/s00134-012-2574-4
Sander, 2010, Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function, J. Exp. Med., 207, 1453, 10.1084/jem.20091474
Cuenca, 2012, Myeloid-derived suppressor cells in sepsis: friend or foe?, Intensive Care Med., 38, 928, 10.1007/s00134-012-2575-3
Dai, 2015, Myeloid-derived suppressor cells: paradoxical roles in infection and immunity, J. Innate Immun., 7, 116, 10.1159/000368233
Lai, 2014, Myeloid-derived suppressor cells in sepsis, Biomed. Res. Int., 2014, 598654, 10.1155/2014/598654
Zhao, 2014, Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors, J. Immunother. Cancer, 2, 12, 10.1186/2051-1426-2-12
Li, 2017, Platelets as autonomous drones for hemostatic and immune surveillance, J. Exp. Med., 214, 2193, 10.1084/jem.20170879
Lievens, 2011, Platelets in atherosclerosis, Thromb. Haemost., 106, 827
Schulz, 2012, Platelets in atherosclerosis and thrombosis, Handb. Exp. Pharmacol., 210, 111, 10.1007/978-3-642-29423-5_5
Li, 2017, Platelets as autonomous drones for hemostatic and immune surveillance, J. Exp. Med.
Semple, 2010, Platelets and innate immunity, Cell. Mol. Life Sci., 67, 499, 10.1007/s00018-009-0205-1
Mancuso, 2017, Platelets: much more than bricks in a breached wall, Br. J. Haematol., 178, 209, 10.1111/bjh.14653
Koupenova, 2018, Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis, Circ. Res., 122, 337, 10.1161/CIRCRESAHA.117.310795
Morrell, 2014, Emerging roles for platelets as immune and inflammatory cells, Blood, 123, 2759, 10.1182/blood-2013-11-462432
Jayachandran, 2007, In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk, J. Appl. Physiol., 102, 429, 10.1152/japplphysiol.01576.2005
Andonegui, 2005, Platelets express functional Toll-like receptor-4, Blood, 106, 2417, 10.1182/blood-2005-03-0916
Aslam, 2006, Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo, Blood, 107, 637, 10.1182/blood-2005-06-2202
Shiraki, 2004, Expression of Toll-like receptors on human platelets, Thromb. Res., 113, 379, 10.1016/j.thromres.2004.03.023
Cognasse, 2005, Evidence of Toll-like receptor molecules on human platelets, Immunol. Cell Biol., 83, 196, 10.1111/j.1440-1711.2005.01314.x
Clark, 2007, Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood, Nat. Med., 13, 463, 10.1038/nm1565
Patrignani, 2006, Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo, Blood, 107, 3572, 10.1182/blood-2005-12-4811
Fabrice, 2007, Platelets as Potential Immunomodulators: Is There a Role for Platelet Toll-Like Receptors?, Curr. Immunol. Rev., 3, 109, 10.2174/157339507780655522
Rondina, 2011, The septic milieu triggers expression of spliced tissue factor mRNA in human platelets, J. Thromb. Haemost., 9, 748, 10.1111/j.1538-7836.2011.04208.x
Cognasse, 2015, The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors, Front. Immunol., 6, 83, 10.3389/fimmu.2015.00083
Hamzeh-Cognasse, 2015, Platelets and infections - complex interactions with bacteria, Front. Immunol., 6, 82, 10.3389/fimmu.2015.00082
Cognasse, 2008, Platelets "Toll-like receptor" engagement stimulates the release of immunomodulating molecules, Transfus. Clin. Biol., 15, 139, 10.1016/j.tracli.2008.07.010
Cognasse, 2008, Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets, Br. J. Haematol., 141, 84, 10.1111/j.1365-2141.2008.06999.x
Cognasse, 2008, Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment, Transfusion, 48, 809, 10.1111/j.1537-2995.2008.01655.x
de Stoppelaar, 2016, Toll-Like Receptor Signalling Is Not Involved in Platelet Response to Streptococcus pneumoniae In Vitro or In Vivo, PLoS One, 11, 10.1371/journal.pone.0156977
Senturk, 2010, Platelet function in inflammatory diseases: insights from clinical studies, Inflamm. Allergy Drug Targets, 9, 355, 10.2174/187152810793938026
Ferrer-Acosta, 2014, Emerging Roles for Platelets in Inflammation and Disease, J. Infect. Dis. Ther., 2, 149
Thomas, 2015, The role of platelets in inflammation, Thromb. Haemost., 114, 449
Carestia, 2016, Platelets: New Bricks in the Building of Neutrophil Extracellular Traps, Front. Immunol., 7, 271, 10.3389/fimmu.2016.00271
Rondina, 2014, Emerging evidence for platelets as immune and inflammatory effector cells, Front. Immunol., 5, 653, 10.3389/fimmu.2014.00653
Blair, 2009, Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase, Circ. Res., 104, 346, 10.1161/CIRCRESAHA.108.185785
Biswas, 2017, TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia, Circ. Res., 121, 951, 10.1161/CIRCRESAHA.117.311069
Panigrahi, 2013, Engagement of Platelet Toll-Like Receptor 9 by Novel Endogenous Ligands Promotes Platelet Hyper-Reactivity and Thrombosis, Circ. Res., 112, 103, 10.1161/CIRCRESAHA.112.274241
Kumar, 2010, Mast cells: emerging sentinel innate immune cells with diverse role in immunity, Mol. Immunol., 48, 14, 10.1016/j.molimm.2010.07.009
Krystel-Whittemore, 2015, Mast Cell: A Multi-Functional Master Cell, Front. Immunol., 6, 620
Frossi, 2017, Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses, Trends Immunol., 38, 648, 10.1016/j.it.2017.04.001
Mrabet-Dahbi, 2009, Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands, Exp. Dermatol., 18, 437, 10.1111/j.1600-0625.2009.00878.x
Li, 2009, NF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharide, Int. Arch. Allergy Immunol., 150, 122, 10.1159/000218115
Matsushima, 2004, TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells, J. Immunol., 173, 531, 10.4049/jimmunol.173.1.531
McCurdy, 2001, Toll-like receptor 4-mediated activation of murine mast cells, J. Leukoc. Biol., 70, 977, 10.1189/jlb.70.6.977
Varadaradjalou, 2003, Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells, Eur. J. Immunol., 33, 899, 10.1002/eji.200323830
Keck, 2011, Absence of TRIF signaling in lipopolysaccharide-stimulated murine mast cells, J. Immunol., 186, 5478, 10.4049/jimmunol.1000458
Kagan, 2008, TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta, Nat. Immunol., 9, 361, 10.1038/ni1569
Kagan, 2012, Signaling organelles of the innate immune system, Cell, 151, 1168, 10.1016/j.cell.2012.11.011
Kagan, 2012, Defining the subcellular sites of innate immune signal transduction, Trends Immunol., 33, 442, 10.1016/j.it.2012.06.005
Dietrich, 2010, Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria, Proc. Natl. Acad. Sci. U. S. A., 107, 8748, 10.1073/pnas.0912551107
Lee, 2012, Accessory molecules for Toll-like receptors and their function, Nat. Rev. Immunol., 12, 168, 10.1038/nri3151
Zanoni, 2011, CD14 controls the LPS-induced endocytosis of Toll-like receptor 4, Cell, 147, 868, 10.1016/j.cell.2011.09.051
Tamassia, 2007, The MyD88-independent pathway is not mobilized in human neutrophils stimulated via TLR4, J. Immunol., 178, 7344, 10.4049/jimmunol.178.11.7344
Jersmann, 2005, Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells, Immunol. Cell Biol., 83, 462, 10.1111/j.1440-1711.2005.01370.x
Kulka, 2004, Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3, J. Allergy Clin. Immunol., 114, 174, 10.1016/j.jaci.2004.03.049
Kulka, 2006, TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin, Mol. Immunol., 43, 1579, 10.1016/j.molimm.2005.09.019
Yoshioka, 2007, Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2, J. Allergy Clin. Immunol., 120, 452, 10.1016/j.jaci.2007.03.027
Ross, 1994, The role of T lymphocytes in inflammation, Proc. Natl. Acad. Sci. U. S. A., 91, 2879, 10.1073/pnas.91.8.2879
Li, 2015, How regulatory T cells sense and adapt to inflammation, Cell. Mol. Immunol., 12, 519, 10.1038/cmi.2015.65
Skapenko, 2005, The role of the T cell in autoimmune inflammation, Arthritis Res. Ther., 7, S4, 10.1186/ar1703
van der Veeken, 2016, Memory of Inflammation in Regulatory T Cells, Cell, 166, 977, 10.1016/j.cell.2016.07.006
Hotchkiss, 2005, Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways, J. Immunol., 174, 5110, 10.4049/jimmunol.174.8.5110
Le Tulzo, 2002, Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome, Shock, 18, 487, 10.1097/00024382-200212000-00001
Inoue, 2013, Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly, Crit. Care Med., 41, 810, 10.1097/CCM.0b013e318274645f
Cao, 2015, The role of regulatory T cells in immune dysfunction during sepsis, World J Emerg Med, 6, 5, 10.5847/wjem.j.1920-8642.2015.01.001
Markwart, 2014, Immunosuppression after Sepsis: Systemic Inflammation and Sepsis Induce a Loss of Naïve T-Cells but No Enduring Cell-Autonomous Defects in T-Cell Function, PLoS ONE, 9, 10.1371/journal.pone.0115094
Condotta, 2013, T-cell mediated immunity and the role of TRAIL in sepsis-induced immunosuppression, Crit. Rev. Immunol., 33, 23, 10.1615/CritRevImmunol.2013006721
Cabrera-Perez, 2014, Impact of sepsis on CD4 T cell immunity, J. Leukoc. Biol., 96, 767, 10.1189/jlb.5MR0114-067R
Wang, 1994, Sepsis-induced apoptosis of the thymocytes in mice, J. Immunol., 152, 5014, 10.4049/jimmunol.152.10.5014
Boomer, 2011, Immunosuppression in patients who die of sepsis and multiple organ failure, JAMA, 306, 2594, 10.1001/jama.2011.1829
Kasten, 2010, T cells are potent early mediators of the host response to sepsis, Shock, 34, 327, 10.1097/SHK.0b013e3181e14c2e
Venet, 2004, Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes, Crit. Care Med., 32, 2329, 10.1097/01.CCM.0000145999.42971.4B
Taylor, 2010, Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype, J. Immunol., 185, 6591, 10.4049/jimmunol.1002416
Wisnoski, 2007, The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis, Shock, 27, 251, 10.1097/01.shk.0000239780.33398.e4
Venet, 2006, Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism, J. Immunol., 177, 6540, 10.4049/jimmunol.177.9.6540
Heuer, 2005, Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis, J. Immunol., 174, 7141, 10.4049/jimmunol.174.11.7141
Chen, 2007, Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells, J. Immunol., 179, 154, 10.4049/jimmunol.179.1.154
Hornung, 2002, Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides, J. Immunol., 168, 4531, 10.4049/jimmunol.168.9.4531
Mansson, 2006, Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis, Respir. Res., 7, 36, 10.1186/1465-9921-7-36
Zarember, 2002, Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines, J. Immunol., 168, 554, 10.4049/jimmunol.168.2.554
Peng, 2005, Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function, Science, 309, 1380, 10.1126/science.1113401
Zanin-Zhorov, 2006, Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling, J. Clin. Invest., 116, 2022, 10.1172/JCI28423
Crellin, 2005, Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells, J. Immunol., 175, 8051, 10.4049/jimmunol.175.12.8051
Caramalho, 2003, Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide, J. Exp. Med., 197, 403, 10.1084/jem.20021633
Tomita, 2008, MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4+ T cells in chronic colitis, J. Immunol., 180, 5291, 10.4049/jimmunol.180.8.5291
Sobek, 2004, Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease, Arthritis Res. Ther., 6, R433, 10.1186/ar1212
Cottalorda, 2006, TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation, Eur. J. Immunol., 36, 1684, 10.1002/eji.200636181
Gelman, 2004, Toll-like receptor ligands directly promote activated CD4+ T cell survival, J. Immunol., 172, 6065, 10.4049/jimmunol.172.10.6065
Fukata, 2008, The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease, J. Immunol., 180, 1886, 10.4049/jimmunol.180.3.1886
MacLeod, 2007, T cell activation by TLRs: a role for TLRs in the adaptive immune response, Sci. STKE, 2007, 10.1126/stke.4022007pe48
Karim, 2017, Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function, Eur. J. Immunol., 47, 1513, 10.1002/eji.201646846
Rahman, 2009, The contribution of direct TLR signaling to T cell responses, Immunol. Res., 45, 25, 10.1007/s12026-009-8113-x
Kabelitz, 2007, Expression and function of Toll-like receptors in T lymphocytes, Curr. Opin. Immunol., 19, 39, 10.1016/j.coi.2006.11.007
Kelly-Scumpia, 2011, B cells enhance early innate immune responses during bacterial sepsis, J. Exp. Med., 208, 1673, 10.1084/jem.20101715
Rawlings, 2012, Integration of B cell responses through Toll-like receptors and antigen receptors, Nat. Rev. Immunol., 12, 282, 10.1038/nri3190
Martin, 2001, Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens, Immunity, 14, 617, 10.1016/S1074-7613(01)00129-7
McHeyzer-Williams, 2003, B cells as effectors, Curr. Opin. Immunol., 15, 354, 10.1016/S0952-7915(03)00046-3
Monserrat, 2013, Early alterations of B cells in patients with septic shock, Crit. Care, 17, R105, 10.1186/cc12750
Suzuki, 2016, Reduced Immunocompetent B Cells and Increased Secondary Infection in Elderly Patients With Severe Sepsis, Shock, 46, 270, 10.1097/SHK.0000000000000619
Hua, 2013, TLR signaling in B-cell development and activation, Cell. Mol. Immunol., 10, 103, 10.1038/cmi.2012.61
Bekeredjian-Ding, 2009, Toll-like receptors – sentries in the B-cell response, Immunology, 128, 311, 10.1111/j.1365-2567.2009.03173.x
Bekeredjian-Ding, 2007, Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands, J. Immunol., 178, 2803, 10.4049/jimmunol.178.5.2803
Ruprecht, 2006, Toll-like receptor stimulation as a third signal required for activation of human naive B cells, Eur. J. Immunol., 36, 810, 10.1002/eji.200535744
Hasan, 2005, Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88, J. Immunol., 174, 2942, 10.4049/jimmunol.174.5.2942
Won, 2008, CD36 is differentially expressed on B cell subsets during development and in responses to antigen, J. Immunol., 180, 230, 10.4049/jimmunol.180.1.230
Buchta, 2014, Toll-like receptors and B cells: functions and mechanisms, Immunol. Res., 59, 12, 10.1007/s12026-014-8523-2
Tabeta, 2006, The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9, Nat. Immunol., 7, 156, 10.1038/ni1297
Akkaya, 2018, Toll-like receptor 9 antagonizes antibody affinity maturation, Nat. Immunol., 19, 255, 10.1038/s41590-018-0052-z
Isnardi, 2008, IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans, Immunity, 29, 746, 10.1016/j.immuni.2008.09.015
Buchta, 2014, TRAF5 negatively regulates TLR signaling in B lymphocytes, J. Immunol., 192, 145, 10.4049/jimmunol.1301901
Agrawal, 2011, TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors, J. Clin. Immunol., 31, 89, 10.1007/s10875-010-9456-8
Jagannathan, 2009, TLR cross-talk specifically regulates cytokine production by B cells from chronic inflammatory disease patients, J. Immunol., 183, 7461, 10.4049/jimmunol.0901517
Booth, 2011, Modulation of B cell responses by Toll-like receptors, Cell Tissue Res., 343, 131, 10.1007/s00441-010-1031-3
Meyer-Bahlburg, 2007, B cell intrinsic TLR signals amplify but are not required for humoral immunity, J. Exp. Med., 204, 3095, 10.1084/jem.20071250
von Bernuth, 2008, Pyogenic bacterial infections in humans with MyD88 deficiency, Science, 321, 691, 10.1126/science.1158298
Picard, 2003, Pyogenic bacterial infections in humans with IRAK-4 deficiency, Science, 299, 2076, 10.1126/science.1081902
Picard, 2010, Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency, Medicine, 89, 403, 10.1097/MD.0b013e3181fd8ec3
Browne, 2012, Regulation of B-cell responses by Toll-like receptors, Immunology, 136, 370, 10.1111/j.1365-2567.2012.03587.x
Nikolajczyk, 2010, B cells as under-appreciated mediators of non-autoimmune inflammatory disease, Cytokine, 50, 234, 10.1016/j.cyto.2010.02.022
Miyagaki, 2015, Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research, Int. Immunol., 27, 495, 10.1093/intimm/dxv026
Ray, 2017, Mechanisms of Regulatory B cell Function in Autoimmune and Inflammatory Diseases beyond IL-10, J. Clin. Med., 6, 12, 10.3390/jcm6010012
Patel, 2013, Microglia and ischemic stroke: a double-edged sword, Int. J. Physiol. Pathophysiol. Pharmacol., 5, 73
Guruswamy, 2017, Complex Roles of Microglial Cells in Ischemic Stroke Pathobiology: New Insights and Future Directions, Int. J. Mol. Sci., 18, 496, 10.3390/ijms18030496
Mariani, 2009, Microglia in Infectious Diseases of the Central Nervous System, J. NeuroImmune Pharmacol., 4, 448, 10.1007/s11481-009-9170-6
Rock, 2004, Role of Microglia in Central Nervous System Infections, Clin. Microbiol. Rev., 17, 942, 10.1128/CMR.17.4.942-964.2004
Perry, 2014, Microglial priming in neurodegenerative disease, Nat. Rev. Neurol., 10, 217, 10.1038/nrneurol.2014.38
Bsibsi, 2002, Broad expression of Toll-like receptors in the human central nervous system, J. Neuropathol. Exp. Neurol., 61, 1013, 10.1093/jnen/61.11.1013
Olson, 2004, Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs, J. Immunol., 173, 3916, 10.4049/jimmunol.173.6.3916
Farina, 2007, Astrocytes are active players in cerebral innate immunity, Trends Immunol., 28, 138, 10.1016/j.it.2007.01.005
Farina, 2005, Preferential expression and function of Toll-like receptor 3 in human astrocytes, J. Neuroimmunol., 159, 12, 10.1016/j.jneuroim.2004.09.009
Laflamme, 2001, Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components, FASEB J., 15, 155, 10.1096/fj.00-0339com
Lehnardt, 2002, The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS, J. Neurosci., 22, 2478, 10.1523/JNEUROSCI.22-07-02478.2002
Lehnardt, 2003, Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway, Proc. Natl. Acad. Sci. U. S. A., 100, 8514, 10.1073/pnas.1432609100
Bowman, 2003, Cultured astrocytes express toll-like receptors for bacterial products, Glia, 43, 281, 10.1002/glia.10256
Carpentier, 2005, Differential activation of astrocytes by innate and adaptive immune stimuli, Glia, 49, 360, 10.1002/glia.20117
Crack, 2007, Toll-like receptors in the brain and their potential roles in neuropathology, Immunol. Cell Biol., 85, 476, 10.1038/sj.icb.7100103
Hanke, 2011, Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential, Clin. Sci., 121, 367, 10.1042/CS20110164
Lafon, 2006, The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA, J. Mol. Neurosci., 29, 185, 10.1385/JMN:29:3:185
Cameron, 2007, Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals, J. Neurosci., 27, 13033, 10.1523/JNEUROSCI.4290-06.2007
Wadachi, 2006, Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection, J. Dent. Res., 85, 49, 10.1177/154405910608500108
Barajon, 2009, Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia, J. Histochem. Cytochem., 57, 1013, 10.1369/jhc.2009.953539
Ma, 2006, Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis, J. Cell Biol., 175, 209, 10.1083/jcb.200606016
MacLullich, 2008, Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses, J. Psychosom. Res., 65, 229, 10.1016/j.jpsychores.2008.05.019
Piva, 2015, Neuroinflammation in sepsis: sepsis associated delirium, Cardiovasc. Hematol. Disord. Drug Targets, 15, 10, 10.2174/1871529X15666150108112452
Jalleh, 2012, Role of microglia and toll-like receptor 4 in the pathophysiology of delirium, Med. Hypotheses, 79, 735, 10.1016/j.mehy.2012.08.013
Tsuruta, 2016, A clinical perspective of sepsis-associated delirium, J. Intensive Care, 4, 18, 10.1186/s40560-016-0145-4
Land, 2015, The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases: Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine, Sultan Qaboos Univ. Med. J., 15, e157
Vénéreau, 2015, DAMPs from Cell Death to New Life, Front. Immunol., 6
Tang, 2012, PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity, Immunol. Rev., 249, 158, 10.1111/j.1600-065X.2012.01146.x
Rubartelli, 2007, Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox, Trends Immunol., 28, 429, 10.1016/j.it.2007.08.004
Kanzok, 2004, Origin of Toll-like receptor-mediated innate immunity, J. Mol. Evol., 58, 442, 10.1007/s00239-003-2565-8
Palmer, 1991, The recent origins of introns, Curr. Opin. Genet. Dev., 1, 470, 10.1016/S0959-437X(05)80194-7
Koonin, 2006, The origin of introns and their role in eukaryogenesis: a compromise solution to the introns-early versus introns-late debate?, Biol. Direct, 1, 22, 10.1186/1745-6150-1-22
Hoshino, 1999, Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product, J. Immunol., 162, 3749, 10.4049/jimmunol.162.7.3749
Sun, 2006, Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk, Cancer Epidemiol. Biomark. Prev., 15, 480, 10.1158/1055-9965.EPI-05-0645
Sun, 2005, Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk, J. Natl. Cancer Inst., 97, 525, 10.1093/jnci/dji070
Hawn, 2007, A common human TLR1 polymorphism regulates the innate immune response to lipopeptides, Eur. J. Immunol., 37, 2280, 10.1002/eji.200737034
Johnson, 2007, Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy, J. Immunol., 178, 7520, 10.4049/jimmunol.178.12.7520
Trejo-de la, 2014, Relevance of single-nucleotide polymorphisms in human TLR genes to infectious and inflammatory diseases and cancer, Genes Immun., 15, 199, 10.1038/gene.2014.10
Ogus, 2004, The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease, Eur. Respir. J., 23, 219, 10.1183/09031936.03.00061703
Tabel, 2007, Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children, Int. J. Immunogenet., 34, 399, 10.1111/j.1744-313X.2007.00709.x
Kutukculer, 2007, Arg753Gln polymorphism of the human toll-like receptor-2 gene in children with recurrent febrile infections, Biochem. Genet., 45, 507, 10.1007/s10528-007-9091-0
Berdeli, 2005, TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children, J. Mol. Med., 83, 535, 10.1007/s00109-005-0677-x
Ozen, 2006, Arg753Gln TLR-2 polymorphism in familial mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease, J. Rheumatol., 33, 2498
Hamann, 2005, A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis, J. Mol. Med., 83, 478, 10.1007/s00109-005-0643-7
Park, 2004, Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility, Ann. N. Y. Acad. Sci., 1037, 170, 10.1196/annals.1337.028
Eid, 2007, Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus, Transplantation, 84, 511, 10.1097/01.tp.0000276960.35313.bf
Kijpittayarit, 2007, Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation, Clin. Infect. Dis., 44, 1315, 10.1086/514339
Studzińska, 2017, Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children, PLoS ONE, 12, 10.1371/journal.pone.0169420
Wang, 2015, TLR3 gene polymorphisms in cancer: a systematic review and meta-analysis, Chin. J. Cancer, 34, 19, 10.1186/s40880-015-0020-z
Ma, 2016, Association of toll-like receptor 3 polymorphism rs3775291 with age-related macular degeneration: a systematic review and meta-analysis, Sci. Rep., 6, 19718, 10.1038/srep19718
Gorbea, 2010, A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy, J. Biol. Chem., 285, 23208, 10.1074/jbc.M109.047464
Ejghal, 2016, The TLR2 and TLR4 gene polymorphisms in Moroccan visceral leishmaniasis patients, Acta Trop., 158, 77, 10.1016/j.actatropica.2016.02.020
Lei, 2015, Association of TLR4 gene polymorphisms with susceptibility to type 2 diabetes mellitus in the Chinese Han population, Int. Immunopharmacol., 24, 68, 10.1016/j.intimp.2014.11.007
Zerdazi, 2017, TLR4 gene polymorphism associated with lifetime cigarette smoking in bipolar disorder, J. Neuroimmunol., 305, 96, 10.1016/j.jneuroim.2017.01.021
Kiziltas, 2014, TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls, Metab. Syndr. Relat. Disord., 12, 165, 10.1089/met.2013.0120
Meena, 2015, Association of TLR5 Gene Polymorphisms in Ulcerative Colitis Patients of North India and Their Role in Cytokine Homeostasis, PLoS ONE, 10, 10.1371/journal.pone.0120697
Xiao, 2014, Association of TLR4 and TLR5 gene polymorphisms with Graves’ disease in Chinese Cantonese population, Hum. Immunol., 75, 609, 10.1016/j.humimm.2014.05.001
Chen, 2015, Association between toll-like receptors 9 (TLR9) gene polymorphism and risk of pulmonary tuberculosis: meta-analysis, BMC Pulm. Med., 15, 57, 10.1186/s12890-015-0049-4
Wifi, 2017, Toll-like receptors-2 and -9 (TLR2 and TLR9) gene polymorphism in patients with type 2 diabetes and diabetic foot, Medicine, 96, 10.1097/MD.0000000000006760
Noreen, 2015, Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility, Immunol. Res., 62, 234, 10.1007/s12026-015-8640-6
Sharma, 2016, TLR signalling and association of TLR polymorphism with cardiovascular diseases, Vasc. Pharmacol., 87, 30, 10.1016/j.vph.2016.10.008
Schwartz, 2005, Polymorphisms of the Toll-like receptors and human disease, Clin. Infect. Dis., 41, S403
Tokarz, 2016, Cell line donor genotype and its influence on experimental phenotype: Toll-like receptor SNPs and potential variability in innate immunity, Mol. Genet. Metab., 118, 147, 10.1016/j.ymgme.2016.04.011
Opal, 2013, Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial, JAMA, 309, 1154, 10.1001/jama.2013.2194
Shirey, 2013, The TLR4 antagonist Eritoran protects mice from lethal influenza infection, Nature, 497, 498, 10.1038/nature12118
Ulrich, 1995, Monophosphoryl lipid A as an adjuvant. Past experiences and new directions, Pharm. Biotechnol., 6, 495, 10.1007/978-1-4615-1823-5_21
Johnson, 1994, Molecular adjuvants and immunomodulators: new approaches to immunization, Clin. Microbiol. Rev., 7, 277, 10.1128/CMR.7.3.277
Baldridge, 2004, Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents, Expert. Opin. Biol. Ther., 4, 1129, 10.1517/14712598.4.7.1129
Garcon, 2007, GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives, Expert Rev. Vaccines, 6, 723, 10.1586/14760584.6.5.723
Sondak, 2003, Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine, Semin. Cancer Biol., 13, 409, 10.1016/j.semcancer.2003.09.004
North, 2005, Vaccination with BLP25 liposome vaccine to treat non-small cell lung and prostate cancers, Expert Rev. Vaccines, 4, 249, 10.1586/14760584.4.3.249
Uenishi, 2007, Study on the cell wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105): establishment of preparation and analytical methods, Chem. Pharm. Bull., 55, 843, 10.1248/cpb.55.843
Morales, 1976, Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors, J. Urol., 116, 180, 10.1016/S0022-5347(17)58737-6
Simons, 2008, Role of Neutrophils in BCG Immunotherapy for Bladder Cancer, Urol. Oncol., 26, 341, 10.1016/j.urolonc.2007.11.031
Murata, 2008, Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors, Cancer Sci., 99, 1435, 10.1111/j.1349-7006.2008.00832.x
Kato, 2010, Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in vitro, Anticancer Res., 30, 4089
Hennessy, 2010, Targeting Toll-like receptors: emerging therapeutics?, Nat. Rev. Drug Discov., 9, 293, 10.1038/nrd3203
Panter, 2009, Therapeutic applications of nucleic acids as ligands for Toll-like receptors, Curr. Opin. Mol. Ther., 11, 133
Navabi, 2009, A clinical grade poly I:C-analogue (Ampligen) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro, Vaccine, 27, 107, 10.1016/j.vaccine.2008.10.024
Jasani, 2009, Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer, Vaccine, 27, 3401, 10.1016/j.vaccine.2009.01.071
Hemmi, 2002, Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway, Nat. Immunol., 3, 196, 10.1038/ni758
Beutner, 1998, Treatment of genital warts with an immune-response modifier (imiquimod), J. Am. Acad. Dermatol., 38, 230, 10.1016/S0190-9622(98)70243-9
Stanley, 2002, Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential, Clin. Exp. Dermatol., 27, 571, 10.1046/j.1365-2230.2002.01151.x
Schulze, 2005, Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe, Br. J. Dermatol., 152, 939, 10.1111/j.1365-2133.2005.06486.x
O'Neill, 2009, Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer, Pharmacol. Rev., 61, 177, 10.1124/pr.109.001073
Harrison, 2007, Pharmacokinetics of 852A, an Imidazoquinoline Toll-Like Receptor 7-Specific Agonist, Following Intravenous, Subcutaneous, and Oral Administrations in Humans, J. Clin. Pharmacol., 47, 962, 10.1177/0091270007303766
Geller, 2010, Toll-Like Receptor-7 (TLR-7) Agonist Administered Subcutaneously in a Prolonged Dosing Schedule in Heavily Pretreated Recurrent Breast, Ovarian, and Cervix Cancers, Cancer Immunol. Immunother., 59, 1877, 10.1007/s00262-010-0914-1
Engel, 2011, The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system, Expert. Rev. Clin. Pharmacol., 4, 275, 10.1586/ecp.11.5
Dudek, 2007, First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer, Clin. Cancer Res., 13, 7119, 10.1158/1078-0432.CCR-07-1443
Dummer, 2008, An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanoma, Clin. Cancer Res., 14, 856, 10.1158/1078-0432.CCR-07-1938
Agrawal, 2007, Synthetic agonists of Toll-like receptors 7, 8 and 9, Biochem. Soc. Trans., 35, 1461, 10.1042/BST0351461
Goodchild, 2009, Primary leukocyte screens for innate immune agonists, J. Biomol. Screen., 14, 723, 10.1177/1087057109335325
Krieg, 2008, Toll-like receptor 9 (TLR9) agonists in the treatment of cancer, Oncogene, 27, 161, 10.1038/sj.onc.1210911
Iribarren, 2016, Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy, Oncoimmunology, 5, 10.1080/2162402X.2015.1088631
Okamoto, 1967, Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci, Jpn. J. Microbiol., 11, 323, 10.1111/j.1348-0421.1967.tb00350.x
Paavonen, 2009, Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women, Lancet, 374, 301, 10.1016/S0140-6736(09)61248-4
Lehtinen, 2012, Sound efficacy of prophylactic HPV vaccination: Basics and implications, Oncoimmunology, 1, 995, 10.4161/onci.20011
Huang, 2014, Targeting aerobic glycolysis and HIF-1alpha expression enhance imiquimod-induced apoptosis in cancer cells, Oncotarget, 5, 1363, 10.18632/oncotarget.1734
Hoffman, 2005, From the analyst's couch: TLR-targeted therapeutics, Nat. Rev. Drug Discov., 4, 879, 10.1038/nrd1880
Dowling, 2016, Toll-like receptors: the swiss army knife of immunity and vaccine development, Clin. Transl. Immunology., 5, 10.1038/cti.2016.22
Kochling, 2008, Anti-tumor effect of DNA-based vaccination and dSLIM immunomodulatory molecules in mice with Ph+ acute lymphoblastic leukaemia, Vaccine, 26, 4669, 10.1016/j.vaccine.2008.06.094
Parkinson, 2008, The future of toll-like receptor therapeutics, Curr. Opin. Mol. Ther., 10, 21
Perego, 2018, Guanabenz inhibits TLR9 signaling through a pathway that is independent of eIF2alpha dephosphorylation by the GADD34/PP1c complex, Sci. Signal., 11, 10.1126/scisignal.aam8104
Negishi, 2005, Negative regulation of Toll-like-receptor signaling by IRF-4, Proc. Natl. Acad. Sci. U. S. A., 102, 15989, 10.1073/pnas.0508327102
O'Neill, 2008, When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction, Immunity, 29, 12, 10.1016/j.immuni.2008.06.004
Kondo, 2012, Dissecting negative regulation of Toll-like receptor signaling, Trends Immunol., 33, 449, 10.1016/j.it.2012.05.002
Rodriguez-Calvo, 2017, The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases, Expert Opin. Ther. Targets, 21, 291, 10.1080/14728222.2017.1279146
Sun, 2008, TIPE2, a novel negative regulator of innate and adaptive immunity that maintains immune homeostasis, Cell, 133, 415, 10.1016/j.cell.2008.03.026
Mokuno, 2000, Expression of Toll-Like Receptor 2 on γδ T Cells Bearing Invariant Vγ6/Vδ1 Induced by Escherichia coli Infection in Mice, J. Immunol., 165, 931, 10.4049/jimmunol.165.2.931
Funderburg, 2008, Toll-Like Receptor Ligands Induce Human T Cell Activation and Death, a Model for HIV Pathogenesis, PLoS ONE, 3, 10.1371/journal.pone.0001915
Sutmuller, 2006, Toll-like receptor 2 controls expansion and function of regulatory T cells, J. Clin. Investig., 116, 485, 10.1172/JCI25439
Marafini, 2015, TNF-α Producing Innate Lymphoid Cells (ILCs) Are Increased in Active Celiac Disease and Contribute to Promote Intestinal Atrophy in Mice, PLoS ONE, 10, 10.1371/journal.pone.0126291
Kumar, 2014, Innate Lymphoid Cells: Immunoregulatory Cells of Mucosal Inflammation, Eur. J. Inflamm., 12, 11, 10.1177/1721727X1401200102
Boyd, 2014, Human CD117 (cKit)+ Innate Lymphoid Cells Have a Discrete Transcriptional Profile at Homeostasis and Are Expanded during Filarial Infection, PLoS ONE, 9, 10.1371/journal.pone.0108649
Crellin, 2010, Regulation of Cytokine Secretion in Human CD127+ LTi-like Innate Lymphoid Cells by Toll-like Receptor 2, Immunity, 33, 752, 10.1016/j.immuni.2010.10.012
Xu, 2015, Type 3 innate lymphoid cell depletion is mediated by TLRs in lymphoid tissues of simian immunodeficiency virus-infected macaques, FASEB J., 29, 5072, 10.1096/fj.15-276477
Roelofs, 2008, The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions, Arthritis Rheum., 58, 338, 10.1002/art.23217
Mohammad Hosseini, 2015, Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases, Adv. Pharm. Bull., 5, 605, 10.15171/apb.2015.082
Farrugia, 2017, The Role of Toll-Like Receptors in Autoimmune Diseases through Failure of the Self-Recognition Mechanism, Int. J. Inflamm., 2017, 8391230, 10.1155/2017/8391230
Duffy, 2016, Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments, Immunotargets Ther., 5, 69, 10.2147/ITT.S89795
O'Reilly, 2018, Toll Like Receptors in systemic sclerosis: An emerging target, Immunol. Lett., 195, 2, 10.1016/j.imlet.2017.09.001
Jimenez-Dalmaroni, 2016, The critical role of toll-like receptors--From microbial recognition to autoimmunity: A comprehensive review, Autoimmun. Rev., 15, 1, 10.1016/j.autrev.2015.08.009
Isaza-Correa, 2014, Toll-like receptors in the pathogenesis of human B cell malignancies, J. Hematol. Oncol., 7, 57, 10.1186/s13045-014-0057-5
Huang, 2008, TLR signaling by tumor and immune cells: a double-edged sword, Oncogene, 27, 218, 10.1038/sj.onc.1210904
Li, 2014, Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy, World J. Gastroenterol., 20, 17699, 10.3748/wjg.v20.i47.17699
Basith, 2012, Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense, Arch. Pharm. Res., 35, 1297, 10.1007/s12272-012-0802-7
Shi, 2016, Application potential of toll-like receptors in cancer immunotherapy: Systematic review, Medicine, 95, 10.1097/MD.0000000000003951
Barrat, 2008, Development of TLR inhibitors for the treatment of autoimmune diseases, Immunol. Rev., 223, 271, 10.1111/j.1600-065X.2008.00630.x
Kaczanowska, 2013, TLR agonists: our best frenemy in cancer immunotherapy, J. Leukoc. Biol., 93, 847, 10.1189/jlb.1012501
Li, 2017, Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways, Int. J. Mol. Sci., 18, 404, 10.3390/ijms18020404
Du, 2016, Targeting Toll-like receptors against cancer, J. Cancer Metastasis Treat., 2, 463, 10.20517/2394-4722.2016.62
Baird, 2017, Stimulating Innate Immunity to Enhance Radiation Therapy-Induced Tumor Control, Int. J. Radiat. Oncol. Biol. Phys., 99, 362, 10.1016/j.ijrobp.2017.04.014
Okun, 2009, Toll-Like Receptors in Neurodegeneration, Brain Res. Rev., 59, 278, 10.1016/j.brainresrev.2008.09.001
Arroyo, 2011, Toll-like receptors are key players in neurodegeneration, Int. Immunopharmacol., 11, 1415, 10.1016/j.intimp.2011.05.006
Drouin-Ouellet, 2012, Inflammation and neurodegeneration: the story 'retolled', Trends Pharmacol. Sci., 33, 542, 10.1016/j.tips.2012.07.002
van Noort, 2009, Toll-like receptors in the CNS: implications for neurodegeneration and repair, Prog. Brain Res., 175, 139, 10.1016/S0079-6123(09)17509-X
Rosenberger, 2014, The impact of single and pairwise Toll-like receptor activation on neuroinflammation and neurodegeneration, J. Neuroinflammation, 11, 166, 10.1186/s12974-014-0166-7
Gao, 2017, Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics, Front. Physiol., 8, 508, 10.3389/fphys.2017.00508
Achek, 2016, Toll-like receptors: promising therapeutic targets for inflammatory diseases, Arch. Pharm. Res., 39, 1032, 10.1007/s12272-016-0806-9
Kannaki, 2011, Toll-like receptors and their role in animal reproduction, Anim. Reprod. Sci., 125, 1, 10.1016/j.anireprosci.2011.03.008
Girling, 2007, Toll-like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology, Immunol. Cell Biol., 85, 481, 10.1038/sj.icb.7100086
Aflatoonian, 2008, Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression, J. Reprod. Immunol., 77, 7, 10.1016/j.jri.2007.03.014
Hedger, 2011, Toll-like receptors and signalling in spermatogenesis and testicular responses to inflammation—a perspective, J. Reprod. Immunol., 88, 130, 10.1016/j.jri.2011.01.010
Iimuro, 2010, TLRs, NF-κB, JNK, and Liver Regeneration, Gastroenterol. Res. Pract., 2010, 598109, 10.1155/2010/598109
Seki, 2005, Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration, Hepatology, 41, 443, 10.1002/hep.20603
Chen, 2011, Toll-like receptors in acute liver injury and regeneration, Int. Immunopharmacol., 11, 1433, 10.1016/j.intimp.2011.04.023
Braza, 2016, Role of TLRs and DAMPs in allograft inflammation and transplant outcomes, Nat. Rev. Nephrol., 12, 281, 10.1038/nrneph.2016.41
Wu, 2014, Roles of Toll-like receptors in transplantation, Curr. Opin. Organ Transplant., 19, 1, 10.1097/MOT.0000000000000038
Goldstein, 2003, Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection, J. Clin. Invest., 111, 1571, 10.1172/JCI200317573
Leventhal, 2012, Toll-like receptors in transplantation: sensing and reacting to injury, Kidney Int., 81, 826, 10.1038/ki.2011.498
Kesh, 2005, TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation, Ann. N. Y. Acad. Sci., 1062, 95, 10.1196/annals.1358.012
Mezger, 2010, Genetic susceptibility to infections with Aspergillus fumigatus, Crit. Rev. Microbiol., 36, 168, 10.3109/10408410903530619
Bochud, 2008, Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy, J. Infect. Dis., 197, 253, 10.1086/524688
Thuong, 2007, A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis, Genes Immun., 8, 422, 10.1038/sj.gene.6364405
Moore, 2004, Lack of association between Toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus, Clin. Diagn. Lab. Immunol., 11, 1194, 10.1128/CDLI.11.6.1194-1197.2004
Bochud, 2007, Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection, J. Infect. Dis., 196, 505, 10.1086/519693
Al-Qahtani, 2012, Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients, J. Med. Virol., 84, 1353, 10.1002/jmv.23271
Svensson, 2012, Polymorphisms in Toll-like receptor 3 confer natural resistance to human herpes simplex virus type 2 infection, J. Gen. Virol., 93, 1717, 10.1099/vir.0.042572-0
Sironi, 2012, A common polymorphism in TLR3 confers natural resistance to HIV-1 infection, J. Immunol., 188, 818, 10.4049/jimmunol.1102179
Citores, 2011, Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis, Transplant. Proc., 43, 2224, 10.1016/j.transproceed.2011.05.011
Ueta, 2007, Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome, Br. J. Ophthalmol., 91, 962, 10.1136/bjo.2006.113449
Misch, 2008, Toll-like receptor polymorphisms and susceptibility to human disease, Clin. Sci., 114, 347, 10.1042/CS20070214
Agnese, 2002, Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections, J. Infect. Dis., 186, 1522, 10.1086/344893
Balistreri, 2005, Role of TLR4 receptor polymorphisms in Boutonneuse fever, Int. J. Immunopathol. Pharmacol., 18, 655, 10.1177/039463200501800406
Arbour, 2000, TLR4 mutations are associated with endotoxin hyporesponsiveness in humans, Nat. Genet., 25, 187, 10.1038/76048
Tal, 2004, Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease, J. Infect. Dis., 189, 2057, 10.1086/420830
Awomoyi, 2007, Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children, J. Immunol., 179, 3171, 10.4049/jimmunol.179.5.3171
Lorenz, 2002, Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock, Arch. Intern. Med., 162, 1028, 10.1001/archinte.162.9.1028
Netea, 2012, Genetic variation in Toll-like receptors and disease susceptibility, Nat. Immunol., 13, 535, 10.1038/ni.2284
Wlasiuk, 2009, A history of recurrent positive selection at the toll-like receptor 5 in primates, Mol. Biol. Evol., 26, 937, 10.1093/molbev/msp018
Hawn, 2003, A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease, J. Exp. Med., 198, 1563, 10.1084/jem.20031220
Hawn, 2009, Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women, PLoS One, 4, 10.1371/journal.pone.0005990
Tantisira, 2004, Toll-like receptor 6 gene (TLR6): single-nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma, Genes Immun., 5, 343, 10.1038/sj.gene.6364096
Schott, 2007, A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection, J. Hepatol., 47, 203, 10.1016/j.jhep.2007.03.021
Wang, 2011, TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection, PLoS One, 6, 10.1371/journal.pone.0026235
Bochud, 2007, Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection, AIDS, 21, 441, 10.1097/QAD.0b013e328012b8ac